The University of Chicago Header Logo

Connection

Peter H. O'Donnell to Age Factors

Back to Details
This is a "connection" page, showing publications Peter H. O'Donnell has written about Age Factors.
Peter H. O'Donnell
Connection Strength
0.049
Age Factors
  1. Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status. Eur Urol Oncol. 2020 06; 3(3):351-359.
    View in: PubMed
    Score: 0.032
  2. Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012 Jun; 18(6):913-21.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.